Cargando…
Retrospective Real-world Evaluation of Enzalutamide in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) during the COVID-19 Pandemic Compared to Docetaxel in mHSPC Pre-COVID-19
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal College of Radiologists. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833935/ http://dx.doi.org/10.1016/j.clon.2022.11.028 |
_version_ | 1784868348534718464 |
---|---|
author | Gould, A. Muse, A. Thomson, A. McGrane, J. |
author_facet | Gould, A. Muse, A. Thomson, A. McGrane, J. |
author_sort | Gould, A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9833935 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Royal College of Radiologists. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98339352023-01-12 Retrospective Real-world Evaluation of Enzalutamide in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) during the COVID-19 Pandemic Compared to Docetaxel in mHSPC Pre-COVID-19 Gould, A. Muse, A. Thomson, A. McGrane, J. Clin Oncol (R Coll Radiol) Article The Royal College of Radiologists. Published by Elsevier Ltd. 2023-02 2023-01-12 /pmc/articles/PMC9833935/ http://dx.doi.org/10.1016/j.clon.2022.11.028 Text en Copyright © 2022 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Gould, A. Muse, A. Thomson, A. McGrane, J. Retrospective Real-world Evaluation of Enzalutamide in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) during the COVID-19 Pandemic Compared to Docetaxel in mHSPC Pre-COVID-19 |
title | Retrospective Real-world Evaluation of Enzalutamide in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) during the COVID-19 Pandemic Compared to Docetaxel in mHSPC Pre-COVID-19 |
title_full | Retrospective Real-world Evaluation of Enzalutamide in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) during the COVID-19 Pandemic Compared to Docetaxel in mHSPC Pre-COVID-19 |
title_fullStr | Retrospective Real-world Evaluation of Enzalutamide in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) during the COVID-19 Pandemic Compared to Docetaxel in mHSPC Pre-COVID-19 |
title_full_unstemmed | Retrospective Real-world Evaluation of Enzalutamide in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) during the COVID-19 Pandemic Compared to Docetaxel in mHSPC Pre-COVID-19 |
title_short | Retrospective Real-world Evaluation of Enzalutamide in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) during the COVID-19 Pandemic Compared to Docetaxel in mHSPC Pre-COVID-19 |
title_sort | retrospective real-world evaluation of enzalutamide in metastatic hormone sensitive prostate cancer (mhspc) during the covid-19 pandemic compared to docetaxel in mhspc pre-covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833935/ http://dx.doi.org/10.1016/j.clon.2022.11.028 |
work_keys_str_mv | AT goulda retrospectiverealworldevaluationofenzalutamideinmetastatichormonesensitiveprostatecancermhspcduringthecovid19pandemiccomparedtodocetaxelinmhspcprecovid19 AT musea retrospectiverealworldevaluationofenzalutamideinmetastatichormonesensitiveprostatecancermhspcduringthecovid19pandemiccomparedtodocetaxelinmhspcprecovid19 AT thomsona retrospectiverealworldevaluationofenzalutamideinmetastatichormonesensitiveprostatecancermhspcduringthecovid19pandemiccomparedtodocetaxelinmhspcprecovid19 AT mcgranej retrospectiverealworldevaluationofenzalutamideinmetastatichormonesensitiveprostatecancermhspcduringthecovid19pandemiccomparedtodocetaxelinmhspcprecovid19 |